ArticleScientific reports2025

LINC00162 silencing enhances sorafenib sensitivity and inhibits thyroid cancer cells progression through modulation of MAPK signaling and apoptosis.

Maryam Hejazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.